Harshad Devarbhavi
Overview
Explore the profile of Harshad Devarbhavi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
3009
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choudhury A, Kulkarni A, Arora V, Soin A, Dokmeci A, Chowdhury A, et al.
Hepatol Int
. 2025 Feb;
19(1):1-69.
PMID: 39961976
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the...
2.
Kumar A, Arora A, Choudhury A, Arora V, Rela M, Jothimani D, et al.
Am J Gastroenterol
. 2024 Jul;
PMID: 39016385
Introduction: The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) and its complication, MAFLD-related acute-on-chronic liver failure (MAFLD-ACLF), is rising. Yet, factors determining patient outcomes in MAFLD-ACLF remain understudied. Methods:...
3.
Thanapirom K, Treeprasertsuk S, Choudhury A, Verma N, Dhiman R, Al Mahtab M, et al.
Sci Rep
. 2024 Mar;
14(1):5796.
PMID: 38461166
The relationship between ammonia and liver-related complications (LRCs) in acute-on-chronic liver failure (ACLF) patients is not clearly established. This study aimed to evaluate the association between ammonia levels and LRCs...
4.
Patil M, Devarbhavi H, Mishra A, Pavan Kumar Y, Dhali G, Chowdhury A
J Clin Exp Hepatol
. 2024 Jan;
14(3):101322.
PMID: 38283703
Background: Hormonal oral contraceptive (OC) agents such as estrogen or progesterone, either as single agents or in combination, and a non-hormonal drug like ormeloxifene are used for various conditions. However,...
5.
Veena M, Ruben J, Chacko Kunjumon N, Devarbhavi H
J Addict Dis
. 2023 Oct;
42(4):456-463.
PMID: 37830122
Background: There are limited studies on barriers to seeking treatment for Alcohol Use Disorders (AUD) among males in tertiary care centers in India and abroad. Identification of these factors can...
6.
Devarbhavi H, Venkatachala P, Devamsh G, Shalimar , Aashik Y, Patil M, et al.
Int J Gynaecol Obstet
. 2023 Sep;
163(3):1030-1032.
PMID: 37753869
No abstract available.
7.
Shankarappa B, Mahadevan J, Murthy P, Purushottam M, Viswanath B, Jain S, et al.
Indian J Gastroenterol
. 2023 Aug;
42(6):800-807.
PMID: 37589914
Background: Genetic and epigenetic factors are associated with the development of alcohol-associated liver disease (AALD). The single nucleotide polymorphisms (SNPs), rs738409 in Patatin-like phospholipase domain-containing protein (PNPLA3) and rs58542926 in...
8.
Shankarappa B, Mahadevan J, Murthy P, Purushottam M, Viswanath B, Jain S, et al.
DNA Cell Biol
. 2023 Jun;
42(7):364-371.
PMID: 37367217
Alcohol use disorder (AUD) and cirrhosis are key outcomes of excessive alcohol use, and a genetic influence in these outcomes is increasingly recognized. While 80-90% of heavy alcohol users show...
9.
Andrade R, Aithal G, de Boer Y, Liberal R, Gerbes A, Regev A, et al.
J Hepatol
. 2023 May;
79(3):853-866.
PMID: 37164270
Drug-induced liver injury (DILI) can mimic almost all other liver disorders. A phenotype increasingly ascribed to drugs is autoimmune-like hepatitis (ALH). This article summarises the major topics discussed at a...
10.
Devarbhavi H, Asrani S, Arab J, Nartey Y, Pose E, Kamath P
J Hepatol
. 2023 Mar;
79(2):516-537.
PMID: 36990226
Liver disease accounts for two million deaths annually and is responsible for 4% of all deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related deaths occur...